Belviq recall and off-label use in the Dravet community
It is not uncommon in a rare disease like Dravet syndrome (DS) to have a physician prescribe a medication for “off-label” use by their patient. This means that the drug is not being used in the manner specified in the FDA’s approved package labeling and is being used for a disease that it is not […]
Belviq recall and off-label use in the Dravet community Read More »